• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测和预防精神分裂症症状的发作和复发:当前实证证据的元分析。

Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence.

机构信息

Department of Psychology.

Department of Psychiatry, Research Center of the Montreal University Institute of Mental Health, University of Montreal.

出版信息

J Abnorm Psychol. 2019 Nov;128(8):840-854. doi: 10.1037/abn0000447. Epub 2019 Jul 25.

DOI:10.1037/abn0000447
PMID:31343181
Abstract

The stress-vulnerability-protective factors model is often used to explain the etiology and known risk and protective factors of initial psychotic symptoms and symptomatic relapses. Over the past 40 years since its initial conception, the model has evolved and gathered a plethora of evidence of varying quality for its different components. The objective of this metareview is to analyze the quality of the evidence and the effect sizes for each component of the model not previously reviewed. Recent meta-analyses covering each component of the model in relation to the onset of psychotic symptoms or symptomatic relapse in schizophrenia were reviewed with the grading of recommendations, assessment, development, and evaluation system. Thirty-one meta-analyses were kept, from 3,044 papers reviewed. We did not add to previous metareviews in terms of obstetric/prenatal or genetic vulnerabilities. For stressors, moderate to strong research evidence was found for childhood adversity, cannabis, methamphetamine abuse, and expressed emotions as triggers of psychotic relapse or as linked to the onset of psychotic symptoms. For protective factors, moderate to strong evidence was found for antipsychotic medication in adults, family interventions, social skills training, as well as interventions focusing on recovery management skills. Poor evidence or no evidence (i.e., absence of meta-analyses) were found for the other components of the model. More rigorous studies and systematic reviews are needed in order to validate the various components of the model in regard to symptom onset and relapse. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

摘要

应激易损性保护因素模型常用于解释首发精神病症状和症状复发的病因以及已知的风险和保护因素。自最初提出以来的 40 多年中,该模型不断发展,针对其不同组成部分收集了大量不同质量的证据。本元分析旨在分析该模型各组成部分的证据质量和效应大小,这些内容之前没有被综述过。对与精神分裂症首发精神病症状或症状复发相关的该模型各组成部分的最新荟萃分析,使用推荐、评估、发展和评估系统进行了综述。从审查的 3044 篇论文中保留了 31 项荟萃分析。我们没有在产科/产前或遗传易损性方面增加以前的元分析内容。对于应激源,有中度到高度研究证据表明,童年逆境、大麻、苯丙胺滥用和情绪表达会引发精神病复发或与精神病症状的发生有关。对于保护因素,在成人中使用抗精神病药物、家庭干预、社交技能训练以及关注康复管理技能的干预措施,有中度到高度的证据支持。对于该模型的其他组成部分,证据不足或没有证据(即没有荟萃分析)。为了验证该模型的各个组成部分在症状发作和复发方面的有效性,需要进行更严格的研究和系统综述。

相似文献

1
Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence.预测和预防精神分裂症症状的发作和复发:当前实证证据的元分析。
J Abnorm Psychol. 2019 Nov;128(8):840-854. doi: 10.1037/abn0000447. Epub 2019 Jul 25.
2
Relapse prevention and recovery in the treatment of schizophrenia.精神分裂症治疗中的复发预防与康复
J Clin Psychiatry. 2006;67 Suppl 5:19-23.
3
Psychosocial treatments for schizophrenia.精神分裂症的心理社会治疗
Psychiatry. 1994 May;57(2):104-14. doi: 10.1080/00332747.1994.11024674.
4
Early intervention in psychotic relapse.精神病复发的早期干预。
Clin Psychol Rev. 2001 Nov;21(8):1211-26. doi: 10.1016/s0272-7358(01)00105-2.
5
Protocol for a systematic review of telephone delivered psychosocial interventions on relapse prevention, adherence to psychiatric medication and health risk behaviours in adults with a psychotic disorder.关于对精神疾病成年患者进行电话心理社会干预以预防复发、坚持服用精神科药物及健康风险行为的系统评价方案。
BMJ Open. 2015 Dec 23;5(12):e009985. doi: 10.1136/bmjopen-2015-009985.
6
Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates.针对与家人同住或独自生活的精神分裂症患者进行的为期三年的个人治疗试验,I:研究描述及对复发率的影响
Am J Psychiatry. 1997 Nov;154(11):1504-13. doi: 10.1176/ajp.154.11.1504.
7
Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.长效注射用利培酮用于预防精神分裂症近期首次发作后的复发及控制突破性症状:一项随机临床试验
JAMA Psychiatry. 2015 Aug;72(8):822-9. doi: 10.1001/jamapsychiatry.2015.0270.
8
Pimozide for schizophrenia or related psychoses.匹莫齐特用于治疗精神分裂症或相关精神病。
Cochrane Database Syst Rev. 2013 Nov 5;2013(11):CD001949. doi: 10.1002/14651858.CD001949.pub3.
9
Training to recognise the early signs of recurrence in schizophrenia.培训识别精神分裂症复发的早期迹象。
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD005147. doi: 10.1002/14651858.CD005147.pub2.
10
Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.在一项为期 1 年的非依从性精神分裂症门诊患者观察队列研究中,复发和治疗干预。
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):245-50. doi: 10.1016/j.pnpbp.2011.10.014. Epub 2011 Oct 26.

引用本文的文献

1
Accuracy of machine learning methods in predicting prognosis of patients with psychotic spectrum disorders: a systematic review.机器学习方法预测精神分裂症谱系障碍患者预后的准确性:一项系统评价
BMJ Open. 2025 Feb 25;15(2):e084463. doi: 10.1136/bmjopen-2024-084463.
2
Reasoning and interpretation cognitive biases related to psychotic characteristics: An umbrella-review.与精神病性特征相关的推理和解释认知偏差:一项伞状综述。
PLoS One. 2024 Dec 27;19(12):e0314965. doi: 10.1371/journal.pone.0314965. eCollection 2024.
3
Psychotic relapse prediction via biomarker monitoring: a systematic review.
通过生物标志物监测进行精神病复发预测:一项系统综述。
Front Psychiatry. 2024 Dec 3;15:1463974. doi: 10.3389/fpsyt.2024.1463974. eCollection 2024.
4
Digital Phenotyping in Adults with Schizophrenia: A Narrative Review.精神分裂症成人的数字化表型:叙事综述。
Curr Psychiatry Rep. 2023 Nov;25(11):699-706. doi: 10.1007/s11920-023-01467-z. Epub 2023 Oct 20.
5
Development and validation of a prediction model for rehospitalization among people with schizophrenia discharged from acute inpatient care.急性住院治疗出院的精神分裂症患者再住院预测模型的开发与验证
Front Psychiatry. 2023 Aug 24;14:1242918. doi: 10.3389/fpsyt.2023.1242918. eCollection 2023.
6
Improving Romantic Relationship Functioning Among Young Men With First-Episode Psychosis: Impact of a Novel Group Intervention.改善首发精神病青年的浪漫关系功能:新型团体干预的影响。
Behav Modif. 2023 Sep;47(5):1170-1192. doi: 10.1177/01454455231186586. Epub 2023 Jul 26.
7
Cognitive impairment in adults under compulsory psychiatric care: association with psychotic symptoms and high-dose antipsychotics.强制精神科护理下成年人的认知障碍:与精神病症状和高剂量抗精神病药物的关联
BJPsych Open. 2023 Jun 14;9(4):e108. doi: 10.1192/bjo.2023.83.
8
Clinicians' perceptions of family involvement in the treatment of persons with psychotic disorders: a nested qualitative study.临床医生对家庭参与精神疾病患者治疗的看法:一项嵌套式定性研究
Front Psychiatry. 2023 May 24;14:1175557. doi: 10.3389/fpsyt.2023.1175557. eCollection 2023.
9
Psychotic relapse in people with schizophrenia within 12 months of discharge from acute inpatient care: protocol for development and validation of a prediction model based on a retrospective cohort study in three psychiatric hospitals in Japan.日本三家精神病医院基于回顾性队列研究的精神分裂症患者急性住院治疗出院后12个月内精神病性复发:预测模型开发与验证方案
Diagn Progn Res. 2022 Nov 3;6(1):20. doi: 10.1186/s41512-022-00134-w.
10
Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity.精神病谱系疾病作为前额叶关键期可塑性障碍。
Neuropsychopharmacology. 2023 Jan;48(1):168-185. doi: 10.1038/s41386-022-01451-w. Epub 2022 Sep 30.